Cite
Adam C, Bray TL, Pérez-López AM, et al. A 5-FU Precursor Designed to Evade Anabolic and Catabolic Drug Pathways and Activated by Pd Chemistry . J Med Chem. 2022;65(1):552-561doi: 10.1021/acs.jmedchem.1c01733.
Adam, C., Bray, T. L., Pérez-López, A. M., Tan, E. H., Rubio-Ruiz, B., Baillache, D. J., Houston, D. R., Salji, M. J., Leung, H. Y., & Unciti-Broceta, A. (2022). A 5-FU Precursor Designed to Evade Anabolic and Catabolic Drug Pathways and Activated by Pd Chemistry . Journal of medicinal chemistry, 65(1), 552-561. https://doi.org/10.1021/acs.jmedchem.1c01733
Adam, Catherine, et al. "A 5-FU Precursor Designed to Evade Anabolic and Catabolic Drug Pathways and Activated by Pd Chemistry ." Journal of medicinal chemistry vol. 65,1 (2022): 552-561. doi: https://doi.org/10.1021/acs.jmedchem.1c01733
Adam C, Bray TL, Pérez-López AM, Tan EH, Rubio-Ruiz B, Baillache DJ, Houston DR, Salji MJ, Leung HY, Unciti-Broceta A. A 5-FU Precursor Designed to Evade Anabolic and Catabolic Drug Pathways and Activated by Pd Chemistry . J Med Chem. 2022 Jan 13;65(1):552-561. doi: 10.1021/acs.jmedchem.1c01733. Epub 2022 Jan 03. PMID: 34979089.
Copy
Download .nbib